Anagraphic, anthropomorphic, risk factors and first visit data | | | Identity information and first visit data need to be entered by the physician on site |
HIV information | • | | |
Laboratory examinations | • | | |
Imaging | | • | |
AFB, culture, GeneXpert MTB/RIF | • | | |
GWAS | | • | |
Resistance patterns | | • | Definition of MDR-TB and XDR-TB will be automatically provided based on resistance patterns |
rpoB | • | | |
gyr | • | | |
kat | • | | |
rrs | • | | |
Second-line drugs | | • | |
Treatment/treatment modifications | | • | |
Follow-up | | • | |
Outcome | | | Healthcare providers can mark a TB-episode according to WHO definitions [13] |